Catalent Pharma Solutions, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announces that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage, with a scheduled completion date of 2018.
The expansion includes a new automated, high-speed bottling line suitable for capsule and tablet products. The line will increase packaging capacity by up to 100 bottles per minute and provides for a quick and easy changeover, essential for clinical-scale production.
鈥淕lobally, almost 2,000 industry-sponsored clinical trials were conducted in the last two years,鈥� commented Roel de Nobel, Catalent鈥檚 Vice President, Global Operations, Clinical Supply Services. 鈥淥ur continued investment in the Asia Pacific reflects the importance of, and the continued growth of clinical trials in Asia, driving the need for in-region packaging services鈥�.
This expansion follows the announcement that work is underway to open a new clinical facility outside of Shanghai鈥檚 free trade zone (FTZ). The new facility is expected to be completed in early 2019 and will join the company鈥檚 existing three clinical packaging facilities in the Asia Pacific region, namely in Shanghai鈥檚 Waigaoqiao FTZ, Singapore and Kakegawa, Japan.
In addition to its primary packaging capabilities, the company offers comprehensive clinical supply solutions in the region including clinical supply management, comparator sourcing, FastChain庐 demand-led supply, secondary packaging, storage and global distribution and clinical returns and destruction.